Satya Narayan1, Neeti Sharma2, Akhil Kapoor3, Rajani Sharma4, Narendra Kumar5, Mukesh Singhal3, Ramesh Purohit3, Shankar Lal Jakhar2, Surendra Beniwal6, Harvindra Singh Kumar2, Ajay Sharma2. 1. Department of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Sardar Patel Medical College, Bikaner, 334003 Rajasthan India ; PG Boys Hostel, PBM Hospital Campus, Bikaner, 334003 Rajasthan India. 2. Department of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner, Rajasthan India. 3. Department of Radiation Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Sardar Patel Medical College, Bikaner, 334003 Rajasthan India. 4. PBM Hospital, Bikaner, Rajasthan India. 5. Sardar Patel Medical College, Bikaner, Rajasthan India. 6. Department of Medical Oncology, Acharya Tulsi Regional Cancer Treatment & Research Institute, Bikaner, Rajasthan India.
Abstract
BACKGROUND: The present study summarizes the results of treatment in the form of disease-free survival and overall survival in bulky stage IB2 and locally advanced (stages II-IVA) squamous cell carcinoma of the uterine cervix. The treatment has been given in the form of NACT followed by CCRT in one arm and CCRT in the other arm. MATERIALS AND METHODS: This retrospective study analyzed 713 cervical cancer patients who were treated at our center during 2007 and 2008; out of 713 patients, data of 612 patients have been compared. The patients' data were analyzed retrospectively. Patients had undergone PF 28.6 %, TPF 21.5 %, and only CCRT 49.9 %. Majority of patients were in the age group 41-50 years, while stage wise, mainly stage IIIb and IIb. Disease-free survival was observed on the basis of stage and NACT. The survival analyses were performed using the Kaplan-Meier method. All statistical calculations were done with SPSS Statistics version 20.0. RESULTS: For cancer cervix NACT versus CCRT, the DFS rate was at 5 years (58.3 vs. 41.8 % p = 0.001). NACT followed by CCRT demonstrated significantly superior DFS as compared to definitive CCRT, respectively, TPF (hazard ratio (HR) = 0.248, 95 % confidence interval (CI) 0.123-0.500; p < 0.001), PF (HR = 0.445, 95 % CI 0.266-0.722; p = 0.002). The results of univariate stage, age, and multivariate study show that stage hemoglobin level, interval between external-intracavitary radiation, and type of neoadjuvant chemotherapy were the factors affected survival cervical patients treated with radiation. The grade 3/4 hematologic toxicities were more in the NACT group than CCRT (p < 0.001) while the non-hematological toxicity was not significant; the TPF group experienced more toxicity than PF (p = 0.029). This treatment regimen is feasible as evidenced by the acceptable toxicity of NACT and by the high compliance to radiotherapy. The grade 3/4 hematologic toxicities were more in NACT groups than CCRT (p < 0.001); the TPF group experienced more toxicity than PF (p = 0.029). CONCLUSION: TPF/PF as NACT is feasible and produces impressive responses in cancer cervix.
BACKGROUND: The present study summarizes the results of treatment in the form of disease-free survival and overall survival in bulky stage IB2 and locally advanced (stages II-IVA) squamous cell carcinoma of the uterine cervix. The treatment has been given in the form of NACT followed by CCRT in one arm and CCRT in the other arm. MATERIALS AND METHODS: This retrospective study analyzed 713 cervical cancerpatients who were treated at our center during 2007 and 2008; out of 713 patients, data of 612 patients have been compared. The patients' data were analyzed retrospectively. Patients had undergone PF 28.6 %, TPF 21.5 %, and only CCRT 49.9 %. Majority of patients were in the age group 41-50 years, while stage wise, mainly stage IIIb and IIb. Disease-free survival was observed on the basis of stage and NACT. The survival analyses were performed using the Kaplan-Meier method. All statistical calculations were done with SPSS Statistics version 20.0. RESULTS: For cancer cervix NACT versus CCRT, the DFS rate was at 5 years (58.3 vs. 41.8 % p = 0.001). NACT followed by CCRT demonstrated significantly superior DFS as compared to definitive CCRT, respectively, TPF (hazard ratio (HR) = 0.248, 95 % confidence interval (CI) 0.123-0.500; p < 0.001), PF (HR = 0.445, 95 % CI 0.266-0.722; p = 0.002). The results of univariate stage, age, and multivariate study show that stage hemoglobin level, interval between external-intracavitary radiation, and type of neoadjuvant chemotherapy were the factors affected survival cervical patients treated with radiation. The grade 3/4 hematologic toxicities were more in the NACT group than CCRT (p < 0.001) while the non-hematological toxicity was not significant; the TPF group experienced more toxicity than PF (p = 0.029). This treatment regimen is feasible as evidenced by the acceptable toxicity of NACT and by the high compliance to radiotherapy. The grade 3/4 hematologic toxicities were more in NACT groups than CCRT (p < 0.001); the TPF group experienced more toxicity than PF (p = 0.029). CONCLUSION:TPF/PF as NACT is feasible and produces impressive responses in cancer cervix.
Authors: J E Sardi; A Giaroli; C Sananes; M Ferreira; A Soderini; A Bermudez; L Snaidas; S Vighi; N Gomez Rueda; G di Paola Journal: Gynecol Oncol Date: 1997-10 Impact factor: 5.482
Authors: H Lukka; H Hirte; A Fyles; G Thomas; L Elit; M Johnston; M Fung Kee Fung; G Browman Journal: Clin Oncol (R Coll Radiol) Date: 2002-06 Impact factor: 4.126
Authors: M McCormack; L Kadalayil; A Hackshaw; M A Hall-Craggs; R P Symonds; V Warwick; H Simonds; I Fernando; M Hammond; L James; A Feeney; J A Ledermann Journal: Br J Cancer Date: 2013-05-21 Impact factor: 7.640
Authors: Nilda E Real; Gisela N Castro; F Darío Cuello-Carrión; Claudia Perinetti; Hanna Röhrich; Niubys Cayado-Gutiérrez; Martin E Guerrero-Gimenez; Daniel R Ciocca Journal: Cell Stress Chaperones Date: 2017-06-12 Impact factor: 3.667